197 related articles for article (PubMed ID: 3986740)
1. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
Ersbøll J; Schultz HB; Hougaard P; Nissen NI; Hou-Jensen K
Cancer; 1985 May; 55(10):2442-58. PubMed ID: 3986740
[TBL] [Abstract][Full Text] [Related]
2. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 years.
Lieberman PH; Filippa DA; Straus DJ; Thaler HT; Cirrincione C; Clarkson BD
Am J Med; 1986 Sep; 81(3):365-80. PubMed ID: 3752139
[TBL] [Abstract][Full Text] [Related]
4. A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.
Monfardini S; Rilke F; Valagussa P; Bajetta E; Canetta R; Buzzoni R; Giardini R; Viviani S
Eur J Cancer Clin Oncol; 1984 May; 20(5):609-17. PubMed ID: 6203753
[TBL] [Abstract][Full Text] [Related]
5. A new working formulation of non-Hodgkin's lymphomas. A retrospective study of the new NCI classification proposal in comparison to the Rappaport and Kiel classifications.
Krueger GR; Medina JR; Klein HO; Konrads A; Zach J; Rister M; Janik G; Evers KG; Hirano T; Kitamura H; Bedoya VA
Cancer; 1983 Sep; 52(5):833-40. PubMed ID: 6871825
[TBL] [Abstract][Full Text] [Related]
6. A critical analysis of the classifications of non-Hodgkin's lymphomas.
Nathwani BN
Cancer; 1979 Aug; 44(2):347-84. PubMed ID: 383253
[TBL] [Abstract][Full Text] [Related]
7. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.
Garvin AJ; Simon RM; Osborne CK; Merrill J; Young RC; Berard CW
Cancer; 1983 Aug; 52(3):393-8. PubMed ID: 6344979
[TBL] [Abstract][Full Text] [Related]
8. [A new functional interpretation of malignant lymphomas. The Lukes-Collins classification and its basis].
Maurer R; Lukes RJ
Schweiz Med Wochenschr; 1979 Jan; 109(3):76-86. PubMed ID: 310578
[TBL] [Abstract][Full Text] [Related]
9. The Lukes-Collins and Kiel classifications for non-Hodgkin lymphomas. A retrospective study considering both classifications and their relationships to stage, sex, age, and survival.
Blanco G; Alavaikko M; Apaja-Sarkkinen M; Taskinen PJ
Anticancer Res; 1986; 6(2):267-79. PubMed ID: 3707063
[TBL] [Abstract][Full Text] [Related]
10. The Lukes and Collins classification of non-Hodgkin's lymphomas. 2. A survival study of 301 patients.
Aine R; Alavaikko M; Kataja M
Acta Pathol Microbiol Immunol Scand A; 1982 Jul; 90(4):251-6. PubMed ID: 7124396
[TBL] [Abstract][Full Text] [Related]
11. Concordance of the Kiel and Lukes-Collins classifications of non-Hodgkin's lymphomas.
Lennert K; Collins RD; Lukes RJ
Histopathology; 1983 Jul; 7(4):549-59. PubMed ID: 6604012
[TBL] [Abstract][Full Text] [Related]
12. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.
Cancer; 1982 May; 49(10):2112-35. PubMed ID: 6896167
[TBL] [Abstract][Full Text] [Related]
13. The reproducibility of the Lukes-Collins classification of non-Hodgkin's lymphomas in a retrospective reclassification.
Apaja-Sarkkinen M; Alavaikko M
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):735-41. PubMed ID: 6540176
[TBL] [Abstract][Full Text] [Related]
14. [The Lukes-Collins classification and the Kiel classification of non-Hodgkin's lymphomas].
Blanco G; Alavaikho M; Apaja-Sarkkinen M; Taskinen PJ
Vopr Onkol; 1987; 33(1):46-50. PubMed ID: 3811309
[TBL] [Abstract][Full Text] [Related]
15. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatment.
Straus DJ; Gaynor JJ; Leiberman PH; Filippa DA; Koziner B; Clarkson BD
Am J Med; 1987 Feb; 82(2):247-56. PubMed ID: 3812517
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphomas: a simplified classification scheme.
Krueger GR; Papadakis T; Medina JR
Anticancer Res; 1984; 4(3):103-8. PubMed ID: 6465846
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility and prognostic value of different non-Hodgkin's lymphoma classifications: study based on the clinicopathologic relations found in the EORTC trial (20751).
De Wolf-Peeters C; Caillou B; Diebold J; van Heerde P; van Unnik JA; van den Oord JJ; van Glabbeke M; Somers R
Eur J Cancer Clin Oncol; 1985 May; 21(5):579-84. PubMed ID: 4007023
[TBL] [Abstract][Full Text] [Related]
19. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
Vonderheid EC; Diamond LW; van Vloten WA; Scheffer E; Meijer CJ; Cashell AW; Hardman JM; Lai SM; Hermans J; Matthews MJ
Cancer; 1994 Jan; 73(1):207-18. PubMed ID: 8275427
[TBL] [Abstract][Full Text] [Related]
20. Histopathological correlation of the Kiel with the original Rappaport classification of malignant non-hodgkin lymphomas.
Krüger GR; Grisar T; Lennert K; Schwarze EW; Brittinger G
Blut; 1981 Sep; 43(3):167-81. PubMed ID: 7343013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
